<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:sbh="https://wiki.synbiohub.org/wiki/Terms/synbiohub#" xmlns:sbol="http://sbols.org/v2#" xmlns:ns0="http://www.w3.org/ns/prov#" xmlns:ns1="http://purl.org/dc/elements/1.1/" xmlns:ns2="http://purl.org/dc/terms/" xmlns:ns3="http://purl.obolibrary.org/obo/">
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00099_12_comp/1">
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00099"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_12_comp"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00099_12_sequence/1"/>
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb7b00099_12_comp</sbol:displayId>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00099_5_comp/1">
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00099_5_sequence/1"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00099"/>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_5_comp"/>
    <sbol:displayId>sb7b00099_5_comp</sbol:displayId>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00099_10_sequence/1">
    <sbol:elements>tgaagatcgagccgggttgc</sbol:elements>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00099_10_sequence"/>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:displayId>sb7b00099_10_sequence</sbol:displayId>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00099_3_comp/1">
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_3_comp"/>
    <sbol:displayId>sb7b00099_3_comp</sbol:displayId>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:version>1</sbol:version>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00099_3_sequence/1"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00099"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00099_7_sequence/1">
    <sbol:elements>aaagctcgccgcgttgtttc</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00099_7_sequence"/>
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb7b00099_7_sequence</sbol:displayId>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00099_4_sequence/1">
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb7b00099_4_sequence</sbol:displayId>
    <sbol:elements>gtcgcgcgatcgcttatttgccgactaccttgg</sbol:elements>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00099_4_sequence"/>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00099_11_sequence/1">
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00099_11_sequence"/>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:elements>gtgccgcgcggcagccacatatgatgaatcctaccctggtggtt</sbol:elements>
    <sbol:displayId>sb7b00099_11_sequence</sbol:displayId>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00099_11_comp/1">
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00099_11_sequence/1"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00099"/>
    <sbol:version>1</sbol:version>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:displayId>sb7b00099_11_comp</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_11_comp"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00099_8_comp/1">
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_8_comp"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00099_8_sequence/1"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <sbol:displayId>sb7b00099_8_comp</sbol:displayId>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00099"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00099_3_sequence/1">
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:elements>catatcgcgcgcgtctgattatggagcagcaacgatg</sbol:elements>
    <sbol:displayId>sb7b00099_3_sequence</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00099_3_sequence"/>
    <sbol:version>1</sbol:version>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00099_1_sequence/1">
    <sbol:version>1</sbol:version>
    <sbol:elements>acgctcgtcgtttggtatgg</sbol:elements>
    <sbol:displayId>sb7b00099_1_sequence</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00099_1_sequence"/>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00099_4_comp/1">
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_4_comp"/>
    <sbol:version>1</sbol:version>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:displayId>sb7b00099_4_comp</sbol:displayId>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00099"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00099_4_sequence/1"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00099_2_sequence/1">
    <sbol:displayId>sb7b00099_2_sequence</sbol:displayId>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00099_2_sequence"/>
    <sbol:elements>agcaaccaggcgtttaag</sbol:elements>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00099_5_sequence/1">
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00099_5_sequence"/>
    <sbol:elements>agtccatccacaggcacaac</sbol:elements>
    <sbol:displayId>sb7b00099_5_sequence</sbol:displayId>
    <sbol:version>1</sbol:version>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00099_7_comp/1">
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00099"/>
    <sbol:version>1</sbol:version>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00099_7_sequence/1"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_7_comp"/>
    <sbol:displayId>sb7b00099_7_comp</sbol:displayId>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00099_12_sequence/1">
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:elements>agtggtggtggtggtggtgcctcgagctagccatcggcacgttc</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00099_12_sequence"/>
    <sbol:displayId>sb7b00099_12_sequence</sbol:displayId>
    <sbol:version>1</sbol:version>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00099_9_sequence/1">
    <sbol:version>1</sbol:version>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:displayId>sb7b00099_9_sequence</sbol:displayId>
    <sbol:elements>gtatggcgtgatggccgaac</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00099_9_sequence"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00099_10_comp/1">
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_10_comp"/>
    <sbol:displayId>sb7b00099_10_comp</sbol:displayId>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00099_10_sequence/1"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00099"/>
    <sbol:version>1</sbol:version>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00099_1_comp/1">
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00099_1_sequence/1"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00099"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_1_comp"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:displayId>sb7b00099_1_comp</sbol:displayId>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:version>1</sbol:version>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00099_6_sequence/1">
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00099_6_sequence"/>
    <sbol:displayId>sb7b00099_6_sequence</sbol:displayId>
    <sbol:version>1</sbol:version>
    <sbol:elements>aatgtacggccagcaacgtc</sbol:elements>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00099_6_comp/1">
    <sbol:displayId>sb7b00099_6_comp</sbol:displayId>
    <sbol:version>1</sbol:version>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00099"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_6_comp"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00099_6_sequence/1"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00099_2_comp/1">
    <sbol:version>1</sbol:version>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:displayId>sb7b00099_2_comp</sbol:displayId>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00099"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_2_comp"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00099_2_sequence/1"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00099_8_sequence/1">
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb7b00099_8_sequence</sbol:displayId>
    <sbol:elements>aaatcgcgccgaaggatgtc</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00099_8_sequence"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00099_9_comp/1">
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00099"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00099_9_sequence/1"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_9_comp"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:displayId>sb7b00099_9_comp</sbol:displayId>
    <sbol:version>1</sbol:version>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbh:supplementalFile rdf:resource="file:///C:/Users/JVM/Downloads/sequence_supplementals/synbict_output/pdf"/>
  </sbol:ComponentDefinition>
  <sbol:Collection rdf:about="http://examples.org/sb7b00099/1">
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00099_3_sequence/1"/>
    <ns1:subject>n-alkyl</ns1:subject>
    <ns1:subject>Production Strain</ns1:subject>
    <ns1:subject>iron oxidases</ns1:subject>
    <ns1:subject>Pico</ns1:subject>
    <ns1:subject>MgSO 4</ns1:subject>
    <ns2:title>New Prodigiosin Derivatives Obtained by Mutasynthesis in Pseudomonas putida</ns2:title>
    <ns1:subject>methyl</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_11_comp/1"/>
    <ns1:subject>pyrrole</ns1:subject>
    <ns1:subject>ansamitocin</ns1:subject>
    <ns1:subject>Antibeta-actin</ns1:subject>
    <ns2:created>2017-05-15</ns2:created>
    <ns2:references>Kennedy, J. Mutasynthesis, chemobiosynthesis, and back to semi-synthesis: combining synthetic chemistry and biosynthetic engineering for diversifying natural products Nat. Prod. Rep. 2008. 25:25-34.</ns2:references>
    <ns1:subject>DNA Polymerase</ns1:subject>
    <ns1:subject>antitumor agents</ns1:subject>
    <ns1:subject>eGFP</ns1:subject>
    <ns1:subject>bipyrrole 4-methoxy-2,2&#8242;-bipyrrole-5-carbaldehyde</ns1:subject>
    <ns2:dateCopyrighted>2017</ns2:dateCopyrighted>
    <ns1:subject>MCF7 cells</ns1:subject>
    <ns1:subject>antibiotics</ns1:subject>
    <ns1:subject>mesylate</ns1:subject>
    <ns1:subject>oligonucleotide</ns1:subject>
    <ns1:creator>Luca Laraia</ns1:creator>
    <ns1:subject>Tris-buffered</ns1:subject>
    <ns1:subject>prodiginines</ns1:subject>
    <ns1:subject>PU)</ns1:subject>
    <ns1:subject>MBC (5</ns1:subject>
    <ns2:references>Bruner, S. D. Enzyme catalysis C-H activation is a Reiske business Nat. Chem. 2011. 3:342-343.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00099_1_sequence/1"/>
    <ns1:subject>alkene-pyrrole</ns1:subject>
    <ns1:subject>Sm</ns1:subject>
    <ns2:references>Taft, F., Brunjes, M., Floss, H. G., Czempinski, N., Grond, S., Sasse, F., Kirschning, A. Highly active ansamitocin derivatives: mutasynthesis using an AHBA-blocked mutant ChemBioChem 2008. 9:1057-1060.</ns2:references>
    <ns2:isPartOf rdf:resource="http://pubs.acs.org/journal/asbcd6"/>
    <ns1:subject>Serratia marcescens</ns1:subject>
    <ns1:subject>E.</ns1:subject>
    <ns1:subject>KT2440 mutant strain</ns1:subject>
    <ns1:subject>formaldehyde</ns1:subject>
    <ns1:subject>Hahella</ns1:subject>
    <ns1:rights>Copyright &amp; 2017 American Chemical Society</ns1:rights>
    <ns1:subject>butyl-meta-cycloheptylprodigiosin</ns1:subject>
    <ns2:references>Bilyk, O., Luzhetskyy, A. Metabolic engineering of natural product biosynthesis in actinobacteria Curr. Opin. Biotechnol. 2016. 42:98-107.</ns2:references>
    <ns1:subject>-r2</ns1:subject>
    <ns1:subject>HCl</ns1:subject>
    <ns1:subject>natural product production</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_12_comp/1"/>
    <ns1:creator>Hannah U. C. Brass</ns1:creator>
    <ns1:subject>LC3-II</ns1:subject>
    <ns1:type>research-article</ns1:type>
    <ns1:subject>prodiginine derivative</ns1:subject>
    <ns1:subject>P. putida</ns1:subject>
    <ns2:references>Hanahan, D. Studies on transformation of Escherichia coli with plasmids J. Mol. Biol. 1983. 166:557-580.</ns2:references>
    <ns2:references>Boecker, S., Zobel, S., Meyer, V., Su&#776;ssmuth, R. D. Rational biosynthetic approaches for the production of new-to-nature compounds in fungi Fungal Genet. Biol. 2016. 89:89-101.</ns2:references>
    <ns1:subject>caspase 3/7</ns1:subject>
    <ns2:references>Laraia, L., Ohsawa, K., Konstantinidis, G., Robke, L., Wu, Y.-W., Kumar, K., Waldmann, H. Discovery of novel cinchona-alkaloid-inspired oxazatwistane autophagy inhibitors Angew. Chem., Int. Ed. 2017. 56:2145-2150.</ns2:references>
    <ns2:dateAccepted>2017-05-15</ns2:dateAccepted>
    <ns3:OBI_0002110 rdf:resource="https://doi.org/10.1021/acssynbio.7b00099"/>
    <ns1:creator>Anita Loeschcke</ns1:creator>
    <ns1:subject>glycerol</ns1:subject>
    <ns1:subject>Sca I</ns1:subject>
    <ns1:subject>monopyrrole</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00099_8_sequence/1"/>
    <ns1:subject>methyl group</ns1:subject>
    <ns1:subject>alkyl residue prodiginines</ns1:subject>
    <ns1:subject>human</ns1:subject>
    <ns1:subject>acetate</ns1:subject>
    <ns1:subject>insulin</ns1:subject>
    <ns1:subject>prodiginine alkaloid</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_7_comp/1"/>
    <ns1:subject>LC3</ns1:subject>
    <ns1:subject>aluminum</ns1:subject>
    <ns1:subject>chloroquine</ns1:subject>
    <ns1:subject>2,4-dimethyl-3-ethylpyrrole</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00099_12_sequence/1"/>
    <ns1:subject>CQ</ns1:subject>
    <ns1:creator>Andreas Domro&#776;se</ns1:creator>
    <ns2:references>Williamson, N. R., Fineran, P. C., Leeper, F. J., Salmond, G. P. C. The biosynthesis and regulation of bacterial prodiginines Nat. Rev. Microbiol. 2006. 4:887-899.</ns2:references>
    <ns1:subject>water</ns1:subject>
    <ns2:references>Domro&#776;se, A., Klein, A. S., Hage-Hu&#776;lsmann, J., Thies, S., Svensson, V., Classen, T., Pietruszka, J., Jaeger, K.-E., Drepper, T., Loeschcke, A. Efficient recombinant production of prodigiosin in Pseudomonas putida Front. Microbiol. 2015. 6.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_9_comp/1"/>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00099_11_sequence/1"/>
    <ns1:subject>Kan</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_3_comp/1"/>
    <ns1:subject>DMSO. Polyurethane</ns1:subject>
    <ns1:subject>pigD</ns1:subject>
    <ns1:subject>methanol</ns1:subject>
    <ns1:subject>Oligonucleotides</ns1:subject>
    <ns2:references>Stamelos, V. A., Fisher, N., Bamrah, H., Voisey, C., Price, J. C., Farrell, W. E., Redman, C. W., Richardson, A. The BH3 mimetic obatoclax accumulates in lysosomes and causes their alkalinization PLoS One 2016. 11.</ns2:references>
    <ns1:subject>MBL</ns1:subject>
    <ns1:creator>Thomas Drepper</ns1:creator>
    <ns2:references>Gibson, D. G. (2011) Enzymatic assembly of overlapping DNA fragments. In Method Enzymol ( Christopher, V. , Ed.) Chapter 15, pp 349&#8211;361, Academic Press.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_8_comp/1"/>
    <ns1:subject>pigCD</ns1:subject>
    <ns1:subject>Prodiginines Prodiginines</ns1:subject>
    <ns1:subject>LC3B</ns1:subject>
    <ns1:subject>MBC</ns1:subject>
    <ns1:subject>Enzyme PigC</ns1:subject>
    <ns1:subject>casein</ns1:subject>
    <ns1:subject>IncuCyte Kinetic Caspase-3/7</ns1:subject>
    <ns2:references>Rubinsztein, D. C., Codogno, P., Levine, B. Autophagy modulation as a potential therapeutic target for diverse diseases Nat. Rev. Drug Discovery 2012. 11:709-730.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00099_6_sequence/1"/>
    <ns1:subject>pigE</ns1:subject>
    <ns1:subject>Prodiginine</ns1:subject>
    <ns1:subject>KH 2</ns1:subject>
    <ns1:subject>MBC (5)</ns1:subject>
    <ns2:references>Trofimov, B. A., Mikhaleva, A. b. I., Ivanov, A. V., Shcherbakova, V. S., Ushakov, I. A. Expedient one-pot synthesis of pyrroles from ketones, hydroxylamine, and 1,2-dichloroethane Tetrahedron 2015. 71:124-128.</ns2:references>
    <ns2:abstract>The deeply red-colored natural compound prodigiosin is a representative of the prodiginine alkaloid family, which possesses bioactivities as antimicrobial, antitumor, and antimalarial agents. Various bacteria including the opportunistic human pathogen Serratia marcescens and different members of the Streptomycetaceae and Pseudoalteromonadaceae produce prodiginines. In addition, these microbes generally accumulate many structurally related alkaloids making efficient prodiginine synthesis and purification difficult and expensive. Furthermore, it is known that structurally different natural prodiginine variants display differential bioactivities. In the herein described mutasynthesis approach, 13 different derivatives of prodigiosin were obtained utilizing the GRAS (generally recognized as safe) classified strain Pseudomonas putida KT2440. Genetic engineering of the prodigiosin pathway together with incorporation of synthetic intermediates thus resulted in the formation of a so far unprecedented structural diversity of new prodiginine derivatives in P. putida. Furthermore, the formed products allow reliable conclusions regarding the substrate specificity of PigC, the final condensing enzyme in the prodigiosin biosynthesis pathway of S. marcescens. The biological activity of prodigiosin toward modulation of autophagy was preserved in prodiginine derivatives. One prodiginine derivative displayed more potent autophagy inhibitory activity than the parent compound or the synthetic clinical candidate obatoclax.</ns2:abstract>
    <ns1:subject>Xho I</ns1:subject>
    <ns2:references>Williamson, N. R., Simonsen, H. T., Ahmed, R. A. A., Goldet, G., Slater, H., Woodley, L., Leeper, F. J., Salmond, G. P. C. Biosynthesis of the red antibiotic, prodigiosin, in Serratia: identification of a novel 2-methyl-3-n-amyl-pyrrole (MAP) assembly pathway, definition of the terminal condensing enzyme, and implications for undecylprodigiosin biosynthesis in Streptomyces Mol. Microbiol. 2005. 56:971-989.</ns2:references>
    <ns2:references>Mu&#776;lhardt, C. (2008) In Der Experimentator: Molekularbiologie/Genomics, Spektrum Akademischer Verlag.</ns2:references>
    <ns1:subject>ethanol</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_5_comp/1"/>
    <ns1:subject>PigC</ns1:subject>
    <ns1:subject>metabolic
engineering</ns1:subject>
    <ns1:subject>2-methyl-3-alkyl-prodiginines</ns1:subject>
    <ns1:subject>Autophagy</ns1:subject>
    <ns1:subject>II)</ns1:subject>
    <ns1:subject>alkene-pyrroles</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00099_2_sequence/1"/>
    <ns1:subject>p62</ns1:subject>
    <ns2:references>Trofimov, B. A., Mikhaleva, A. I., Vasil&#712;ev, A. N., Korostova, S. Y., Shevchenko, S. G. Pyrroles from Ketoximes and Acetylene. 29. Synthesis of Alkylpyrroles from Dialkylketoximes and Dichloroethane by Reaction with KOH-DMSO Chem. Heterocycl. Compd. 1985. 21:46-49.</ns2:references>
    <ns1:subject>E. coli DH5&#945; cells</ns1:subject>
    <ns2:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00099_4_sequence/1"/>
    <ns1:subject>oligonucleotides</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_10_comp/1"/>
    <ns2:references>Fu&#776;rstner, A. Chemie und Biologie des Roseophilins und der Prodigiosin-Alkaloide: 2500 Jahre im U&#776;berblick Angew. Chem. 2003. 115:3706-3728.</ns2:references>
    <ns1:subject>streptomycin</ns1:subject>
    <ns2:references>Arellano, M. L., Borthakur, G., Berger, M., Luer, J., Raza, A. A phase II, multicenter, open-label study of obatoclax mesylate in patients with previously untreated myelodysplastic syndromes with anemia or thrombocytopenia Clin. Lymphoma Myeloma Leuk. 2014. 14:534-539.</ns2:references>
    <ns2:dateSubmitted>2017-03-28</ns2:dateSubmitted>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_4_comp/1"/>
    <ns1:subject>GRAS</ns1:subject>
    <ns1:subject>DMSO</ns1:subject>
    <sbol:version>1</sbol:version>
    <ns2:isPartOf>ACS Synthetic Biology</ns2:isPartOf>
    <ns0:wasDerivedFrom rdf:resource="https://pubs.acs.org/doi/10.1021/acssynbio.7b00099"/>
    <ns1:subject>GFP</ns1:subject>
    <ns1:subject>sodium chloride</ns1:subject>
    <ns1:subject>gentamicin</ns1:subject>
    <ns1:subject>Tween20</ns1:subject>
    <ns1:subject>MAP (6a)</ns1:subject>
    <ns1:subject>cycloprodigiosin</ns1:subject>
    <ns1:subject>Caspase 3/7</ns1:subject>
    <ns1:subject>potassium phosphate</ns1:subject>
    <ns1:creator>Andreas S. Klein</ns1:creator>
    <ns1:subject>r2</ns1:subject>
    <ns2:rightsHolder>American Chemical Society</ns2:rightsHolder>
    <ns2:references>Oki, Y., Copeland, A., Hagemeister, F., Fayad, L. E., Fanale, M., Romaguera, J., Younes, A. Experience with obatoclax mesylate (GX15&#8211;070), a small molecule pan&#8211;Bcl-2 family antagonist in patients with relapsed or refractory classical Hodgkin lymphoma Blood 2012. 119:2171-2172.</ns2:references>
    <ns1:subject>l-glutamine</ns1:subject>
    <ns1:subject>pyrrole-precursor</ns1:subject>
    <ns1:subject>protein p62</ns1:subject>
    <ns1:subject>fed</ns1:subject>
    <ns1:subject>pig-r2</ns1:subject>
    <ns1:subject>S. marcescens</ns1:subject>
    <ns1:subject>pig</ns1:subject>
    <ns1:subject>prodigiosin (1a)</ns1:subject>
    <ns2:references>Loeschcke, A., Markert, A., Wilhelm, S., Wirtz, A., Rosenau, F., Jaeger, K. E., Drepper, T. TREX: A universal tool for the transfer and expression of biosynthetic pathways in bacteria ACS Synth. Biol. 2013. 2:22-33.</ns2:references>
    <ns1:subject>Escherichia coli</ns1:subject>
    <ns2:references>Stankovic, N., Senerovic, L., Ilic-Tomic, T., Vasiljevic, B., Nikodinovic-Runic, J. Properties and applications of undecylprodigiosin and other bacterial prodigiosins Appl. Microbiol. Biotechnol. 2014. 98:3841-3858.</ns2:references>
    <ns2:references>Simon, R., Priefer, U., Pu&#776;hler, A. A broad host range mobilization system for in vivo genetic engineering: Transposon mutagenesis in gram negative bacteria Nat. Biotechnol. 1983. 1:784-791.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00099_7_sequence/1"/>
    <ns1:subject>IPTG</ns1:subject>
    <ns2:references>Chawrai, S.
R., Williamson, N. R., Salmond, G. P. C., Leeper, F. J. Chemoenzymatic synthesis of prodigiosin analogues-exploring the substrate specificity of PigC Chem. Commun. 2008.</ns2:references>
    <ns1:subject>pyrroles</ns1:subject>
    <ns1:subject>amine-containing drugs</ns1:subject>
    <ns1:subject>LB Kan</ns1:subject>
    <ns1:subject>mutasynthesis</ns1:subject>
    <ns2:references>Langer, C. J., Albert, I., Ross, H. J., Kovacs, P., Blakely, L. J., Pajkos, G., Somfay, A., Zatloukal, P., Kazarnowicz, A., Moezi, M. M., Schreeder, M. T., Schnyder, J., Ao-Baslock, A., Pathak, A. K., Berger, M. S. Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer Lung Cancer 2014. 85:420-428.</ns2:references>
    <ns2:references>Weist, S., Kittel, C., Bischoff, D., Bister, B., Pfeifer, V., Nicholson, G. J., Wohlleben, W., Su&#776;ssmuth, R. D. Mutasynthesis of glycopeptide antibiotics: Variations of vancomycin&#8217;s AB-ring amino acid 3,5-dihydroxyphenylglycine J. Am. Chem. Soc. 2004. 126:5942-5943.</ns2:references>
    <ns1:subject>Stock</ns1:subject>
    <ns1:subject>non</ns1:subject>
    <ns1:creator>Jo&#776;rg Pietruszka</ns1:creator>
    <ns1:subject>amino acids</ns1:subject>
    <ns2:references>Papireddy, K., Smilkstein, M., Kelly, J. X., Shweta, , Salem, S. M., Alhamadsheh, M., Haynes, S. W., Challis, G. L., Reynolds, K. A. Antimalarial activity of natural and synthetic Prodiginines J. Med. Chem. 2011. 54:5296-5306.</ns2:references>
    <ns3:OBI_0001617>28505410</ns3:OBI_0001617>
    <ns2:references>Studier, F. W., Moffatt, B. A. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes J. Mol. Biol. 1986. 189:113-130.</ns2:references>
    <ns1:subject>2,4-dimethylpyrrole</ns1:subject>
    <ns1:subject>2-methyl-3-amylpyrrole</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00099_9_sequence/1"/>
    <ns1:subject>aadA</ns1:subject>
    <ns1:subject>autophagy activator</ns1:subject>
    <ns2:references>Dong, L. B., Rudolf, J. D., Shen, B. A Mutasynthetic library of platensimycin and platencin Analogues Org. Lett. 2016. 18:4606-4609.</ns2:references>
    <ns1:subject>DNA polymerase</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_2_comp/1"/>
    <sbol:displayId>sb7b00099</sbol:displayId>
    <ns1:subject>undecylprodigiosin</ns1:subject>
    <ns1:subject>alkyl chain</ns1:subject>
    <ns1:subject>alkaloids</ns1:subject>
    <ns1:subject>prodiginine</ns1:subject>
    <ns2:references>Hu, D. X., Withall, D. M., Challis, G. L., Thomson, R. J. Structure, chemical synthesis, and biosynthesis of prodiginine natural products Chem. Rev. 2016. 116:7818-7853.</ns2:references>
    <ns2:references>Kirschning, A., Taft, F., Knobloch, T. Total synthesis approaches to natural product derivatives based on the combination of chemical synthesis and metabolic engineering Org. Biomol. Chem. 2007. 5:3245-3259.</ns2:references>
    <ns2:references>Gregory, M. A., Petkovic, H., Lill, R. E., Moss, S. J., Wilkinson, B., Gaisser, S., Leadlay, P. F., Sheridan, R. M. Mutasynthesis of rapamycin analogues through the manipulation of a gene governing starter unit biosynthesis Angew. Chem., Int. Ed. 2005. 44:4757-4760.</ns2:references>
    <ns1:subject>alkene&#8211;pyrrole</ns1:subject>
    <ns1:subject>difluoride</ns1:subject>
    <ns1:subject>platensimycin</ns1:subject>
    <ns1:subject>diethyl ether</ns1:subject>
    <ns1:subject>tryptone</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00099_5_sequence/1"/>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_6_comp/1"/>
    <ns2:references>Nisha, K. K., Kumar, V. Prodigiosin alkaloids: recent advancements in total synthesis and their biological potential RSC Adv. 2015. 5:10899-10920.</ns2:references>
    <ns1:subject>pigC</ns1:subject>
    <ns1:creator>Karl-Erich Jaeger</ns1:creator>
    <ns1:subject>pigCaadApigD</ns1:subject>
    <ns2:references>Chawrai, S.
R., Williamson, N. R., Mahendiran, T., Salmond, G. P. C., Leeper, F. J. Characterisation of PigC and HapC, the prodigiosin synthetases from Serratia sp and Hahella chejuensis with potential for biocatalytic production of anticancer agents Chem. Sci. 2012. 3:447-454.</ns2:references>
    <ns1:creator>Patrick Bongen</ns1:creator>
    <ns1:subject>500 mL cultures</ns1:subject>
    <ns1:subject>isopropyl &#946;-d-1-thiogalactopyranoside</ns1:subject>
    <ns1:subject>S17&#8211;1</ns1:subject>
    <ns1:subject>prodiginines.</ns1:subject>
    <ns1:subject>Pseudomonas putida</ns1:subject>
    <ns2:references>Schimmer, A. D., Raza, A., Carter, T. H., Claxton, D., Erba, H., DeAngelo, D. J., Tallman, M. S., Goard, C., Borthakur, G. A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemia PLoS One 2014. 9.</ns2:references>
    <ns1:subject>prodignines</ns1:subject>
    <ns1:subject>E. coli</ns1:subject>
    <ns1:subject>Obatoclax</ns1:subject>
    <ns2:references>The synthesis of pure 2-butyl-3-pentylpyrrole via the Trofimov reaction is not possible. The [3,3] sigmatropic rearrangement does not show any regioselectivity using 5-undecanonoxime. Therefore the reaction provided a mixture of the desired product and 2-hexyl 3-propylpyrrole.</ns2:references>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00099_1_comp/1"/>
    <ns1:subject>SQSTM1</ns1:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00099_10_sequence/1"/>
    <ns1:subject>MAP</ns1:subject>
    <ns1:subject>DMSO.</ns1:subject>
    <ns1:subject>vancomycin</ns1:subject>
    <ns1:subject>monopyrroles</ns1:subject>
    <ns2:description>The deeply red-colored natural compound prodigiosin is a representative of the prodiginine alkaloid family, which possesses bioactivities as antimicrobial, antitumor, and antimalarial agents. Various bacteria including the opportunistic human pathogen Serratia marcescens and different members of the Streptomycetaceae and Pseudoalteromonadaceae produce prodiginines. In addition, these microbes generally accumulate many structurally related alkaloids making efficient prodiginine synthesis and purification difficult and expensive. Furthermore, it is known that structurally different natural prodiginine variants display differential bioactivities. In the herein described mutasynthesis approach, 13 different derivatives of prodigiosin were obtained utilizing the GRAS (generally recognized as safe) classified strain Pseudomonas putida KT2440. Genetic engineering of the prodigiosin pathway together with incorporation of synthetic intermediates thus resulted in the formation of a so far unprecedented structural diversity of new prodiginine derivatives in P. putida. Furthermore, the formed products allow reliable conclusions regarding the substrate specificity of PigC, the final condensing enzyme in the prodigiosin biosynthesis pathway of S. marcescens. The biological activity of prodigiosin toward modulation of autophagy was preserved in prodiginine derivatives. One prodiginine derivative displayed more potent autophagy inhibitory activity than the parent compound or the synthetic clinical candidate obatoclax.</ns2:description>
    <ns1:subject>tripyrrolic natural compound</ns1:subject>
    <ns1:subject>dichloromethane</ns1:subject>
    <ns1:subject>chemically competent cells</ns1:subject>
    <ns1:subject>sodium pyruvate</ns1:subject>
    <ns1:subject>KT2440</ns1:subject>
    <ns1:subject>polyurethane</ns1:subject>
    <ns1:subject>oligonucleotides.</ns1:subject>
    <ns1:subject>Bcl-2</ns1:subject>
    <ns1:subject>Goat</ns1:subject>
    <ns1:subject>bromophenol blue</ns1:subject>
    <sbol:persistentIdentity rdf:resource="http://examples.org/sb7b00099"/>
    <ns1:subject>Prodiginines</ns1:subject>
    <ns1:subject>alkyl</ns1:subject>
    <ns2:references>Perez-Tomas, R., Montaner, B., Llagostera, R., Soto-Cerrato, V. The prodigiosins, proapoptotic drugs with anticancer properties Biochem. Pharmacol. 2003. 66:1447-1452.</ns2:references>
    <ns1:subject>alkyl moiety</ns1:subject>
    <ns1:subject>P. putida.</ns1:subject>
    <ns1:creator>Thomas Classen</ns1:creator>
    <ns1:creator>Sonja Sievers</ns1:creator>
    <ns1:subject>Phire</ns1:subject>
    <ns1:subject>Actin</ns1:subject>
    <ns1:subject>K 2</ns1:subject>
    <ns2:references>Kaufmann, A. M., Krise, J. P. Lysosomal sequestration of amine-containing drugs: Analysis and therapeutic implications J. Pharm. Sci. 2007. 96:729-746.</ns2:references>
    <ns1:subject>rapamycin</ns1:subject>
    <ns1:subject>Nde</ns1:subject>
    <ns1:publisher>American Chemical
Society</ns1:publisher>
    <ns1:subject>Konstantinidis</ns1:subject>
    <ns1:subject>DE3</ns1:subject>
    <ns1:subject>Eco 72I</ns1:subject>
    <ns1:subject>bovine</ns1:subject>
    <ns1:subject>kanamycin</ns1:subject>
  </sbol:Collection>
</rdf:RDF>
